A clinical study to evaluate the efficacy and safety of Ayurvedic medicines in the treatment of Agnimandya (an Ayurvedic disease entity, may be correlated to functional dyspepsia)

Clinical evaluation of Sanjivani vati and Pippaladyasava in the management of Agnimandya - a randomized parallel group study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/054028

Enrollment

110

Registered

2023-06-16

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K30- Functional dyspepsia

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either sex with age between 18 and 60 years. 2. Patients having any six sign and symptoms of Agnimandya out of 10 (below mentioned) along with reduced Abhyavaharan Shakti, (capacity to eat), Jarana Shakti (capacity to digest), and Ruchi (appetite) for the past one week. 1 Avipaka 2 Aruchi 3 Udaragaurava 4 Shirorogaurava 5 Praseka 6 Chhardi 7 Kasa 8 Shwasa 9 Gatrasada 10 Malavarodha 3. Willing to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Patients of age 60 years. 2. Patients in whom Agnimandya is caused due to intake of medicine. 3. Patients having Tikshagni (hyper functioning of digestion and metabolic activities), and Samagni (moderate Agni) 4. Patients having any established disease of Gastro-intestinal tracts. 5. Immuno-compromised states and patients with systemic infections or known cases of AIDS, HIV, STD etc. 6. Patients with severe/history of cardiac, hepatic, cerebro-vascular disease, pulmonary dysfunction, malignancy, chronic uncontrolled systemic diseases or renal disorder (S. Creatinine >1.2 mg/dl) etc or poorly controlled Hypertension (Blood pressure more than 160/100mm of Hg), uncontrolled Diabetes Mellitus (HbA1c>=8), or any other serious medical illness. 7. Patients on medication with corticosteroids or any other drugs that may have an influence on the outcome of the study. 8. History of hypersensitivity to the trial drug or any of its ingredients. 9. Patients who have completed participation in any other clinical trial during the past three months. 10. Any other condition, which the Investigator thinks, may jeopardize the study.

Design outcomes

Primary

Measure	Time frame
Change in sign and symptoms of AgnimandyaTimepoint: At Baseline, seventh day, fourteenth day and on day 21	—

Secondary

Measure	Time frame
â?¢Change in Agnibala. (Agni Pariksha tool developed by CCRAS) â?¢Change in quality of life by using SF-36 Score Timepoint: At Baseline, seventh day, fourteenth day and on day 21	—

Countries

India

Contacts

Public ContactDr Babita Yadav

Central Council for Research in Ayurvedic Sciences

drbabitayadav@gmail.com9910171143

Outcome results